Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid’s Cell Therapy Programs
Myeloid to utilize MaxCyte’s Flow Electroporation® technology and [...]
Myeloid to utilize MaxCyte’s Flow Electroporation® technology and [...]
Gaithersburg, Maryland – November 9, 2020: MaxCyte, Inc., a global [...]
GAITHERSBURG, MD, November 9, 2020 — MaxCyte, Inc., a [...]
Gaithersburg, Maryland – October 13, 2020: MaxCyte, Inc., a [...]
New parallel cohort will broaden evaluation of MCY-M11 in [...]
Gaithersburg, Maryland – September 10, 2020: MaxCyte, a global [...]
Murphy brings a wealth of life sciences capital markets [...]
APEIRON to utilize MaxCyte’s ExPERT® platform for siRNA-based [...]
R-1000, a cuvette that can process up to 1 [...]
Solebury Trout, Goodwin, Deutsche Bank and Nasdaq to present [...]